Mitochondrial dynamics is a highly dysregulated process in cancer.
Introduction
Breast cancer is one of the leading causes of death in women worldwide. Treatment of breast cancer includes radiation, surgery and chemotherapy. The majority of breast tumors are hormone-dependent and they account for about 70% of breast cancers. About 80% of breast cancers are "ER-positive", i.e. the cancer cells grow in response to the hormone estrogen 1 . About 65% of these are also "PR-positive" (Progesterone receptor). Tumors that are ER/PRpositive are much more likely to respond to hormone therapy than tumors that are ER/PRnegative. Triple negative breast cancer (TNBC) lacks all three receptors i.e.ER, PR, and Her2. The Cancer therapy that targets these receptors does not work well with TNBC tumor 2 . The development of drug resistance to chemotherapy is one of the major hurdles in treatment of breast cancer 3 . The existing therapeutic approaches are not sufficient to root-out breast cancer. Consequently, development of novel drugs that target tumors irrespective of their hormone receptor status have a potential to strengthen the fight against breast cancer.
A growing number of studies have shown that microRNAs play key roles in the regulation of several cellular processes, whilst microRNA expression profiling has been associated with tumor development, progression and response to therapy 4, 5 . MiRNAs are 20-25 nucleotide long sequences of non-coding RNA that regulate gene expression post transcriptionally. MiRNAs mimics and antagomiR have been widely used to normalize miRNA expression and hence gene expression networks in disease conditions 6 . The ability of miRNA to restore gene expression to physiologically normal level renders microRNA-based strategies a potential therapeutic approach.
In several studies hsa-miR-195 has been reported to be differentially expressed in normal and breast cancer tissues 7, 8, 9, 10 . A decrease in has-miR-195 expression in cancer tissue is due to increased methylation on CpG Island of miR-195 promoter 11, 12 . Further, increased circulatory level of hsa-miR-195 in breast cancer patients and decline in circulatory miR-195 post-operation make hsa-miR-195 a potential biomarker for breast cancer 13, 14, 15 . In previous studies we have unveiled a pro-apoptotic role of miR-195 in breast cancer and we have demonstrated that miR-195 downregulates Bcl2 by direct binding to its 3'UTR Sequence 16 . In another study we have further shown the anti-proliferative, non-invasive and anti-metastatic role of hsa-miR-195 in breast cancer cells 17 . These findings suggest hsa-miR-195 has strong anticancer properties with a promising therapeutic potential in breast cancer. Besides its pro-apoptotic role, hsa-miR-195 has also been shown to depolarize the mitochondrial inner membrane and to increase the calcium concentration in mitochondria 17 . Despite all previous studies it remains unclear how miR-195 affects mitochondrial function. During our in-silico analysis we observed that mitofusin-2 (MFN2) acts as a predicted target of hsa-miR-195. Further reanalyzing our illumina microarray data, we found a differential expression of MFN2 upon over-expression of miR-195 in breast cancer cells. Herein, we have validated mitofusin-2 as a direct target of miR-195 in breast cancer cell lines. Over-expression of miR-195 in breast cancer cell induces mitochondrial fragmentation and diminishes the ability of mitochondrion to consume oxygen. The observed functional impairment of mitochondria induced by miR-195 is independent of the ER (Estrogen receptor) status of cells.
Results

MiR-195 down regulates MFN2 in Breast cancer cell lines
We have previously shown that miR-195 affects mitochondrial functioning by means of depolarization of the inner membrane and disturbing calcium homeostasis within the organelle 17 . However the exact mechanism by which theses processes are controlled was not investigated.
In-silico analysis using target scan revealed a miR-195 binding site in the 3'UTR of MFN2 (Figure1A). Mitofusin-2 is a crucial protein known to play a role in controlling mitochondrial dynamics and maintenance of mitochondrial calcium homeostasis. The miR-195 was upregulated using pSilencermiR-195 (miR) cloned vector whereas down regulated using antimiR-195 (AM)(Figure1B). As shown in Figure 1C 
MiR-195 affects mitochondrial morphology
Mitochondrial morphology is a critical factor that determines its activity. MFN2 has been shown to affect mitochondrial dynamics by promoting fusion events and hence mitochondrial morphology. Mitotracker CMXRos has been used to check morphology of the organelle. We observed increase fragmentation of mitochondria when we over-expressed miR-195 in MCF-7 and MDA-MB-231 cell lines ( Figure 2 ). The highly networked tubular mitochondria in untreated cells tend to become rounded and small fragmented in shape upon over-expression of miR-195 in both cell lines, the complete fragmented morphology of mitochondria was observed in cells treated with CCCP i.e. the positive control ( Figure 2 ).
MiR-195 promotes mitochondrial fission by blocking fusion event
Mitochondrial morphology is critical for its functioning and it is regulated by mitochondrial dynamics. Apart from mitofusins there are other proteins whose levels change markedly during the mitochondrial fusion and fission events. Here we found that up-regulation of miR-195 affects the levels of both DRP1 (dynamin related protein) and OPA1. Specifically, in MCF-7 cells, DRP1 increases 1.9-fold ( Figure 3A MiR-195 diminishes active mitochondrial mass but does not promote degradation of mitochondria through mitophagy Mitophagy and mitochondrial dynamics are two inter-connected process needed to maintain fully functional mitochondria by targeting defective and damaged mitochondria to a dedicated degradation process. Mitophagy is not the only process by which a healthy pool of mitochondria is maintained since damaged mitochondria can also undergo a repair pathway or they can fuse with completely healthy mitochondria and compensate the damage. As fusion events are blocked by the miR-195 by targeting MFN2 therefore fusion of damaged mitochondria with healthy ones is no longer an option for mitochondria to overcome the damaging oxidative stress. We have therefore checked for mitochondrial mass and mitophagy. The VDAC1 and mtHSP70 proteins are used as mitochondrial mass markers whilst PINK1 is used as a mitophagy marker. Upon over-expression of miR-195 or knockdown of miR-195 none of these markers ( Figure 4A for PINK1, 4B for VDAC1, 4C mtHSP70 protein) have shown any significant difference compared to vehicle control in MCF-7 and MDA-MB-231 cell lines. These observations clearly suggest that miR-195 does not promote degradation through mitophagy of damaged mitochondria and hence total mitochondria mass does not change. We further probed for the functionally active mitochondria pool using mitotracker CMXRos (which is highly dependent on a functional mitochondrial transmembrane potential). We observed a decrease of active mass of mitochondria upon miR-195 treatment in MCF-7 and MDA-MB-231 cell lines. On the other hand, the mass of active mitochondria increased upon down-regulation of miR-195 in both cell lines. CCCP treatment was used as a positive control. Taken together, these observations suggest that miR-195-mediated mitochondrial membrane depolarization is not severe enough to induce mitophagy, but it is sufficient to diminish mitochondrial activity and hence the pool of active mitochondria.
MiR-195 induces a defect in mitochondrial respiration
To further validate the effect of miR-195 on aerobic respiration, the Oxygen consumption rates of mitochondria (OCR) was measured directly with a SeaHorse-XF24 flux analyzer. The overexpression of miR-195 shows a potential respiratory defect as OCR is reduced, whilst downregulation of mir-195 resulted in an increase in OCR in both the MCF-7 and the MDA-MB-231 cell lines. The OCR was used to further calculate other respiratory parameters such as basal respiration, maximal respiration, ATP production and spare respiratory capacity of mitochondria. miR-195 appears to attenuate basal respiration by 0. 
Oxidative stress is augmented by miR-195
The mitochondria are a prime source of energy production in cells, wherein, it utilizes the proton gradient across the membrane to generate ATP and convert molecular oxygen into water as a byproduct. The process of oxidative phosphorylation and electron transfer constantly takes place in inner mitochondrial membrane of metabolically active cells. The activity and proper assembly of electron transport chain complexes plays a central role in the electron flow and generation of the proton gradient across the membrane. Any defect in the ETC components leads to leakage of electrons to the mitochondrial matrix and that in turn converts molecular oxygen to superoxide, a damaging ROS. To check the effect of miR-195 on oxidative stress, we have probed for mitochondrial superoxide using Mitosox Red, a fluorescent probe that is rapidly oxidized by superoxides in mitochondria and produces red fluorescence. The over-expression of miR-195 enhanced superoxide levels 1.2-fold in MCF-7 cells and 1.13-fold in MDA-MB-231 cells. This increase in mitochondrial ROS suggests the involvement of ETC in the effect exerted by miR-195 on mitochondrial dynamics. To further examine the effects on ROS, we checked the expression of MnSOD2 as it is the key scavenger of superoxide in the matrix of mitochondria. Interestingly, the level of MnSOD2 increased 1. figure 6A, 6B ). This additional evidence supports the role of miR-195 in maintaining the mitochondrial superoxide concentration at nondamaging levels by up-regulating its main scavenger protein (MnSOD2) and hence bypassing the mitophagy process.
Discussion
Healthy mitochondria play a critical role in the determination of cell fate and the maintenance of cellular homeostasis. Mitochondrial dysfunction is a pathological hallmark for different diseases and stress-induced mitochondrial dysfunction is known to activate the intrinsic pathway of apoptosis 18, 19, 20, 21 . The dynamic nature of mitochondria ensures their quality, whilst unhealthy mitochondria with irreparable damage undergo a specific degradation process called mitophagy 22, 23, 24, 25, 26 . A healthy pool of mitochondria is maintained by a series of fusion-fission events.
Mitofusin1 and Mitofusin2 facilitate fusion of the outer mitochondrial membrane 27, 28, 29 , while the inner mitochondrial membrane gets fused by the inner membrane GTPase protein OPA1 30, 31, 32 . Mitochondrial fission is triggered upon localization of the DRP1 and FIS1 proteins on scissor site 33, 34, 35, 36 . In conclusion, mitochondrial dynamics and mitochondria morphology are highly linked process that plays a major role in mitochondrial quality control to maintain cellular homeostasis.
Previously we demonstrated that hsa-miR-195 targets Bcl-2, it causes mitochondrial dysfunction, it induces apoptosis and augments the effect of etoposide in breast cancer cells. We further demonstrated that miR-195 also targets genes involved in de novo lipogenesis, it inhibits cell proliferation, migration, and invasion by targeting FASN, HMGCR, ACACA and CYP27B1 thereby potentially opening new avenues for the treatment of breast cancer. However, the underlying mechanism by which miR-195 causes mitochondrial dysfunction remains unexplored.
Herein, we first checked whether miR-195 can regulate mitochondrial shape and function. Our current findings revealed that miR-195 modulates mitochondrial shape and enhances fragmentation of mitochondria in breast cancer cells (Figure2). We also identified MFN2 to be a direct target of miR-195 in apoptotic breast cancer cell lines. The expression of MFN2 has been shown by other groups to be implicated in various cancers 37 . The overexpression of MFN2 has been observed to enhance tumorigenesis while inhibition of MFN2 has been revealed to exert anti-cancer effects 38 . Further, MFN2 has been shown to affect mitochondrial dynamics by promoting fusion events. In an independent study Leboucher and colleagues reported that the phosphorylation and proteosomal degradation of MFN2 under stress condition facilitates mitochondrial fission and apoptosis 39 . Therefore targeting MFN2 using miR-195 expands the therapeutic potential of candidate microRNA.
We further demonstrated that miR-195 reduces the efficiency of mitochondria to consume oxygen. The observed differential levels of OPA1 and DRP1 upon alteration of miR-195 expression further suggested an indirect involvement of both proteins in modulation of mitochondrial dynamics by miR-195. Next, we were curious to know the fate of fragmented mitochondria in apoptotic breast cancer cells upon up-regulation of miR-195. Mitochondrial fission and increased oxidative stress is often known to decrease mitochondrial mass by committing damaged mitochondria to mitophagy. However, to our surprise, we did not observe any change in mitochondrial mass and hence no mitophagy but there was a decrease in the mass of active mitochondria. Taken together, these observations suggest that miR-195 affects mitochondrial functions and enhances oxidative stress but the stress is not sufficient to trigger mitophagy. It seems that miR-195 induces moderate oxidative stress to compromise mitochondrial activity and that is the reason behind a reduced mass of active mitochondria.
Further, to check how the moderate level of stress is being maintained by miR-195, we analyzed the mitochondrial MnSOD2 and observed significant up regulation of superoxide scavenging in mitochondria under the influence of miR-195. This illustrates a very subtle effect of miR-195 that enhances oxidative stress on the one hand by affecting mitochondrial dynamics, whilst it does not allow excess ROS accumulation by enhancing the level of the scavenger (MnSOD2).
The role of pro-apoptotic miR-195 in modulation of mitochondrial dynamics by targeting MFN2 renders miR-195 an effective anticancer molecule. Our results revealed miR-195 mediated potential respiratory defects in MCF-7 and MDA-MB-231 cell lines that characterize miR-195 as a modulator of mitochondrial respiration. The current study gives detailed mechanistic insight into the mitochondrial functional impairment by miR-195 in apoptotic breast cancer cell lines. The results presented here expand our previous finding that miR-195 mediates differential expression of components of the mitochondrial electron transfer chain in breast cancer cell lines miR-195 as a putative potential therapeutic molecule not just in cancer but various metabolic as well as neurodegenerative diseases where mitochondrial function is being compromised.
Methods
Cell culture
Human breast adeno carcinoma cell lines MCF-7 and MDA-MB-231 were procured from National Centre for Cell Sciences (NCCS), Pune, India and cultured using DMEM containing 10% (v/v) fetal calf serum, 100 Units/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin at 37 °C in a humidified atmosphere at 5% CO2.
MiR-195 over-expression and knockdown
Over-expression of miR-195 was achieved using p195 (237 bp sequence containing premiR-195 cloned in psilencer 4.1 vector purchased from Ambion, Austin, TX, USA) 16 and pSilencer 4.1 empty vector was used as a control. The miR-195 knockdown was done using AntimiR-195 oligos (AM17000) and AntimiR miRNA inhibitor negative control (AM17010). Both oligos were purchased from Ambion, Austin, TX, USA. Lipofectamine 2000 and Lipofectamine LTX-Plus (Invitrogen, CA, USA) was used for transfection according to manufacturer's protocol. Cells were trypsinized and harvested 24 hours post transfection.
Mitochondrial morphology
The mitochondrial shape was visualized using mitochondria specific probe mitotracker CMXRos 40 . CMXRos is a fluorescent dye that is lipophilic and cationic in nature. CMXRos binds to the negatively charged matrix side of the mitochondrial inner membrane. Cells were stained with 200 nM CMXRos for 15 minutes at 37 ⁰C post miR-195 treatments in cell culture incubator. The mitochondrial proton gradient and ATP synthesis uncoupler Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was used at 50 µM concentration as a positive control to visualize complete fragmentation of mitochondria. The cells were visualized at 63X magnification using fluorescence microscope (Leica DMI6000, Germany)
RNA isolation and TaqMan assay
The miRNA-195 overexpression and knockdown was analyzed using Taqman probes specific to miR-195. The taqMan miRNA assay probes (RT000494 and TM000494) were purchased from applied biosystems. The total RNA was isolated from MCF-7 and MDA-MB-231 cell lines 24 hours post transfections with p195, antimiR-195 and their respective controls. The Trizol reagent (Ambion by Invitrogen, CA, USA) was used as per manufacturer's instructions to isolate total RNA. The Integrity of RNA samples were checked at 1% agarose gel in a TAE buffer system. Quantification was done using a nanodrop and absorbance measurements at 260 nm, 280 nm and 230 nm. Five hundred nanograms of RNA of each sample was used to synthesize c-DNA using RevertAid H minus first strand cDNA synthesis kit as per manufacturer's protocol for 18s r-RNA, whereas miR195-specific cDNA was synthesized using miR-195 specific primer (RT000494) and the TaqMan reverse transcription kit (Applied Biosystems) as per manufacturer's protocol. The expression of matured miR-195 was estimated using TaqMan miRNA assay probe (TM000494, Applied Biosystems), the 18s r-RNA (Ref-4333760F, Applied Biosystems) was used to normalize the miR-195 expression. Data analysis was done using Pfaffl's method 41 .
Protein preparation and Western blotting
Cells were lysed with RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP40, 0.25% Na-deoxycholate, 1 mM EDTA) containing protease inhibitors (1 μg/ml aprotinin, 1 μg/ml pepstatin, 1 μg/ml leupeptin, 1 mM PMSF,1 mM sodium fluoride and 1 mM sodium orthovanadate ) for 30 minutes on ice. The lysates were centrifuged at 16000 g for 30 minutes at 4 °C and the supernatant was collected. Protein concentration was estimated by the BCA (Sigma, USA) method. Equal amount of proteins (50-100 μg) were separated on 10%-12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Separated protein was further transferred to PVDF membrane (Mdi; Advanced Microdevices, India). The membrane was blocked using 5% Bovine serum albumin (BSA) for 1 h at RT and incubated with the respective antibodies in 1% BSA for 16 hours at 4⁰C, blot was washed three times using TBST, and then further incubated with the suitable secondary antibody for 1 hour at room temperature. DRP1, OPA1 and MFN2 antibody were purchased from Abcam (Cambridge, UK) and used at 1:1000 concentrations. VDAC1 antibody was purchased from cell signaling and used at 1:1000 concentrations. β-actin and GAPDH were obtained from Sigma (Sigma, USA) and used at 1:5000 concentrations. β-actin and GAPDH was used as protein loading control to normalize the results. The secondary antibodies were HRP-linked and used at 1:5000 concentration and blots were developed using enhanced chemi-luminiscence (Pierce, Amersham). Integrated density values were calculated using the Image-J software.
Luciferase reporter assay 3′UTR of MFN2 gene was cloned in pSichek2 luciferase vector backbone (Promega, Madison, WI, USA) and 100 ng of plasmid was used along with miR-195 treatment in a 12-well cell culture plate. Luciferase activity was measured using the dual luciferase reporter assay system (Promega, Madison, WI, USA) as per manufacturer's protocol.
Oxygen consumption rate measurement
For metabolic flux measurement cells 60,000 to 80,000 cells were seeded in each well of a XF-24 plate, whilst for the plate that was used as a blank (A1, B4, C3, D6) no cells were seeded in the wells. Transfection of miR-195, AntimiR-195 and their respective controls was done using Lipofectamine 2000 (Invitrogen, CA, USA) reagent at 70% to 80% cell confluency. 24 hours post transfection the cells were washed with XF-24 assay media and incubated in the same buffer for 1 hour at 37 ⁰C in a CO 2 -free environment. A pre-hydrated XF-24 cartridge was loaded with inhibitor in their respective chambers. A cartridge with utility plate was kept in XF-24 flux analyzer machine and the program was run. After the calibration step, the utility plate was replaced with the cell culture plate and the metabolic flux of the cells was measured. The protein estimation was done using the Bradford method post experiment to check the equal seeding density in each well of XF-24 flux analyzer. The data was normalized per microgram of protein 42 .
Mitochondrial mass measurement
Cells were seeded in 12-well plates and treatment was given once the desired confluency was reached. 50 µM CCCP treatment for 2 hours was given as a positive control of mitochondrial mass reduction. Cells were washed post treatments, Staining was done using 200 nM mitotracker CMXRos for 15 min at 37 ⁰C. Cells were washed using PBS and harvested. Cells were further acquired using FACS (EasyCyte Guava Technologies).
Mitochondrial reactive oxygen species measurement
Mitochondrial superoxide was measured using MitosoxRed staining 43 . The cells were seeded in 24 well plate and miR-195 treatment was given at 70% cell confluency. 1 µM rotenone was used as positive control to generate endogenous superoxide radicals. Mitochondrial superoxide was stained using 5 µM MitosoxRed for 20 minutes at 37 ⁰C. Cells were harvested using 0.5% trypsin and washed with PBS. The cells were acquired using FACS (EasyCyte Guava Technologies).
Statistical Analysis
A two-tailed student t-Test was used for statistical analysis. Mean of a minimum of two or a maximum of four independent experiments ±SE is plotted. P-value less than 0.05, less than 0.01 and less than 0.001 is represented by *, ** and *** respectively on plots. 
